Device-lead abnormalities and function after transcatheter tricuspid valve replacement.

ABSTRACT:

Aims

The increasing adoption of transcatheter tricuspid valve replacement (TTVR) offers a promising therapeutic option for patients with severe tricuspid regurgitation. However, many of these patients have pre-existing cardiac implantable electronic devices (CIEDs), raising concerns about potential lead-related complications. Despite these concerns, limited data exist on the impact of TTVR on CIED integrity and function. This study aimed to evaluate the impact of TTVR on CIED lead function, including pacing thresholds, sensing, and impedance, in patients undergoing TTVR with the EVOQUE valve system.

Methods and results

A retrospective observational study was conducted at Mayo Clinic Rochester, including 32 consecutive patients who underwent TTVR with pre-existing CIEDs. A to

SUBMITTER: Abbasi M 

PROVIDER: S-EPMC12528984 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature